Panaccione R - Search Results

1

Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.

Sandborn WJ, D'Haens GR, Reinisch W, Panés J, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG; GALAXI-1 Investigators. Sandborn WJ, et al. Among authors: panaccione r. Gastroenterology. 2022 May;162(6):1650-1664.e8. doi: 10.1053/j.gastro.2022.01.047. Epub 2022 Feb 5. Gastroenterology. 2022. PMID: 35134323 Free article. Clinical Trial.

2

Is antibody testing for inflammatory bowel disease clinically useful?

Panaccione R, Sandborn WJ. Panaccione R, et al. Gastroenterology. 1999 Apr;116(4):1001-2; discussion 1002-3. doi: 10.1016/s0016-5085(99)70087-9. Gastroenterology. 1999. PMID: 10092326 No abstract available.

3

The appendix in ulcerative colitis: a not so innocent bystander.

Panaccione R, Sandborn WJ. Panaccione R, et al. Gastroenterology. 1999 Jul;117(1):272-3. doi: 10.1016/s0016-5085(99)70581-0. Gastroenterology. 1999. PMID: 10381940 No abstract available.

4

Successful management of Crohn's disease of the ileoanal pouch with infliximab.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: panaccione r. Gastroenterology. 1999 Aug;117(2):429-32. doi: 10.1053/gast.1999.0029900429. Gastroenterology. 1999. PMID: 10419926

5

Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.

Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Ricart E, et al. Among authors: panaccione r. Am J Gastroenterol. 2001 Mar;96(3):722-9. doi: 10.1111/j.1572-0241.2001.03612.x. Am J Gastroenterol. 2001. PMID: 11280541

6

Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada.

Panaccione R; Canadian Consensus Group on the use of infliximab in Crohn's disease. Panaccione R, et al. Can J Gastroenterol. 2001 Jun;15(6):371-5. doi: 10.1155/2001/490921. Can J Gastroenterol. 2001. PMID: 11429666 Review.

7

Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.

Feagan BG, Enns R, Fedorak RN, Panaccione R, Paré P, Steinhart AH, Wild G. Feagan BG, et al. Among authors: panaccione r. Can J Clin Pharmacol. 2001 Winter;8(4):188-98. Can J Clin Pharmacol. 2001. PMID: 11743591 Review.

8

The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.

Schwartz DA, Loftus EV Jr, Tremaine WJ, Panaccione R, Harmsen WS, Zinsmeister AR, Sandborn WJ. Schwartz DA, et al. Among authors: panaccione r. Gastroenterology. 2002 Apr;122(4):875-80. doi: 10.1053/gast.2002.32362. Gastroenterology. 2002. PMID: 11910338

9

Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study.

Ricart E, Panaccione R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Ricart E, et al. Among authors: panaccione r. Inflamm Bowel Dis. 2004 May;10(3):207-14. doi: 10.1097/00054725-200405000-00005. Inflamm Bowel Dis. 2004. PMID: 15290913

10

Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.

Panaccione R, Fedorak RN, Aumais G, Bernstein CN, Bitton A, Croitoru K, Enns R, Feagan B, Fishman M, Greenberg G, Griffiths A, Marshall JK, Rasul I, Sadowski D, Seidman E, Steinhart H, Sutherland L, Walli E, Wild G, Williams CN, Zachos M; Canadian Association of Gastroenterology. Panaccione R, et al. Can J Gastroenterol. 2004 Aug;18(8):503-8. doi: 10.1155/2004/670161. Can J Gastroenterol. 2004. PMID: 15372114 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

442 results

Search Page

Filters